Indivior PLC (LON:INDV - Get Free Report) shares dropped 16% during trading on Thursday . The company traded as low as GBX 548.71 ($6.90) and last traded at GBX 729.50 ($9.18). Approximately 78,684,203 shares changed hands during trading, an increase of 2,668% from the average daily volume of 2,842,694 shares. The stock had previously closed at GBX 868 ($10.92).
Analyst Ratings Changes
Separately, Jefferies Financial Group restated a "buy" rating and set a GBX 1,800 ($22.65) price target on shares of Indivior in a research note on Tuesday, December 17th.
Check Out Our Latest Stock Report on Indivior
Indivior Stock Down 15.7 %
The stock has a market capitalization of £1.14 billion, a P/E ratio of -606.93, a P/E/G ratio of -5.57 and a beta of 0.19. The firm's fifty day moving average is GBX 928.06 and its 200-day moving average is GBX 853.71. The company has a current ratio of 0.83, a quick ratio of 1.52 and a debt-to-equity ratio of -170.06.
Indivior Company Profile
(
Get Free Report)
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Indivior, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Indivior wasn't on the list.
While Indivior currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
